Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing.
Cytotherapy. 2024 Apr 7:S1465-3249(24)00600-5. doi: 10.1016/j.jcyt.2024.04.002. Online ahead of print.
Cytotherapy. 2024.
PMID: 38661611
Free article.
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy.
Eriksson RAE, Nieminen T, Galibert L, Peltola SK, Tikkanen P, Käyhty P, Leinonen HM, Oruetxebarria I, Lepola S, Valkama AJ, Lipponen EM, Lesch HP, Ylä-Herttuala S, Airenne KJ.
Eriksson RAE, et al. Among authors: kayhty p.
Front Med (Lausanne). 2023 Mar 3;10:1143748. doi: 10.3389/fmed.2023.1143748. eCollection 2023.
Front Med (Lausanne). 2023.
PMID: 36936246
Free PMC article.
Item in Clipboard
Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy.
Eriksson RAE, Nieminen T, Galibert L, Peltola SK, Tikkanen P, Käyhty P, Lesch HP, Ylä-Herttuala S, Airenne KJ.
Eriksson RAE, et al. Among authors: kayhty p.
Front Med (Lausanne). 2022 Dec 13;9:1052318. doi: 10.3389/fmed.2022.1052318. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 36582287
Free PMC article.
Item in Clipboard
Development of Large-Scale Downstream Processing for Lentiviral Vectors.
Valkama AJ, Oruetxebarria I, Lipponen EM, Leinonen HM, Käyhty P, Hynynen H, Turkki V, Malinen J, Miinalainen T, Heikura T, Parker NR, Ylä-Herttuala S, Lesch HP.
Valkama AJ, et al. Among authors: kayhty p.
Mol Ther Methods Clin Dev. 2020 Mar 30;17:717-730. doi: 10.1016/j.omtm.2020.03.025. eCollection 2020 Jun 12.
Mol Ther Methods Clin Dev. 2020.
PMID: 32346549
Free PMC article.
Item in Clipboard
Cite
Cite